Article(id=1330225287033369318, tenantId=1146029695717560320, journalId=1319690329412173987, issueId=1330225126483800273, articleNumber=null, orderNo=null, doi=10.13683/j.wph.2022.03.020, pmid=null, cstr=null, oa=null, hot=null, price=null, onlineType=0, articleFormat=0, articleType=null, articleTypeStr=null, receivedDate=1629907200000, receivedDateStr=2021-08-26, revisedDate=null, revisedDateStr=null, acceptedDate=null, acceptedDateStr=null, onlineDate=1795080022818, onlineDateStr=2026-11-19, pubDate=1646841600000, pubDateStr=2022-03-10, doiRegisterDate=null, doiRegisterDateStr=null, onlineIssueDate=1795080022818, onlineIssueDateStr=2026-11-19, onlineJustAcceptDate=null, onlineJustAcceptDateStr=null, onlineFirstDate=null, onlineFirstDateStr=null, sourceXml=null, magXml=null, createTime=1795080022818, creator=13701087609, updateTime=1795080022818, updator=13701087609, issue=Issue{id=1330225126483800273, tenantId=1146029695717560320, journalId=1319690329412173987, year='2022', volume='43', issue='3', pageStart='211', pageEnd='341', issueExtLink='null', onlineDate='null', pubDate='1646841600000', pubDateStr='2022-03-10', beforeIssueId=null, nextIssueId=null, price=null, status=1, issueComplete=1, articleOrder=1, issueType=-1, specialIssue=null, createTime=1795079984541, creator='13701087609', updateTime=1795084691298, updator='13701087609', preIssue=null, nextIssue=null, articleTotal=null, ext={EN=IssueExt(id=1330244868573606556, tenantId=1146029695717560320, journalId=1319690329412173987, issueId=1330225126483800273, language=EN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=), CN=IssueExt(id=1330244868573606557, tenantId=1146029695717560320, journalId=1319690329412173987, issueId=1330225126483800273, language=CN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=)}, issueFiles=null, downloadFileDto=null}, startPage=325, endPage=330, ext={EN=ArticleExt(id=1330225287423439591, articleId=1330225287033369318, tenantId=1146029695717560320, journalId=1319690329412173987, language=EN, title=Research progress in almonertinib in the treatment of advanced non-small cell lung cancer, columnId=1325221194584162830, journalTitle=World Clinical Drug, columnName=Review, runingTitle=null, highlight=null, articleAbstract=

Lung cancer is one of the most common malignant tumors in the world, and it is also the leading cause of cancer-related death. Non-small cell lung cancer (NSCLC) is the main type of lung cancer, and epidermal growth factor receptor (EGFR) gene mutation is a common driving gene for NSCLC. The first and second generation epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) are effective in the treatment of NSCLC with EGFR mutation-positive, but they are prone to drug resistance caused by T790M mutation. Almonertinib is a noval and irreversible third generation EGFR-TKI independently developed in China. It has high selectivity to EGFR sensitization and T790M drug resistance mutation and also has good central nervous system activity and tolerance. In this paper, we reviewed the mechanism of action, pharmacodynamics, pharmacokinetics, clinical research and combination therapy of almonertinib, to provide a reference for clinical application.

, authors=Yuhao FU1, 2, Xuejiao XUN1, 2, Xueru HE1, 2, Ran FU1, 2, Yanjun CUI1, 2, Zhanjun DONG2, *, authorsList=Yuhao FU, Xuejiao XUN, Xueru HE, Ran FU, Yanjun CUI, Zhanjun DONG, authorCompany=null, correspAuthors=Zhanjun DONG, authorNote=null, correspAuthorsNote=null, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=null, magXml=null, pdfUrl=null, pdf=null, pdfFileSize=null, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=null, mapNumber=null, fund=null), CN=ArticleExt(id=1330225287746401000, articleId=1330225287033369318, tenantId=1146029695717560320, journalId=1319690329412173987, language=CN, title=阿美替尼治疗晚期非小细胞肺癌的研究进展, columnId=1325221194743546384, journalTitle=世界临床药物, columnName=综述评论, runingTitle=null, highlight=null, articleAbstract=

肺癌(lung cancer)是全球发病率最高的恶性肿瘤之一,也是导致恶性肿瘤相关性死亡的主要原因。其中非小细胞肺癌(non-small cell lung cancer,NSCLC)是主要的肺癌类型,表皮生长因子受体(epidermal growth factor receptor,EGFR)基因突变是其常见的驱动基因。第一、二代表皮生长因子受体酪氨酸激酶抑制剂(epidermal growth factor receptor tyrosine kinase inhibitors,EGFR-TKIs)对EGFR突变阳性的NSCLC疗效确切,但极易出现T790M突变引发的耐药。阿美替尼是我国自主研发的一种新型、不可逆的第3代EGFR-TKI,对EGFR增敏和T790M耐药突变具有高选择性,且具有良好的中枢神经系统活性和耐受性。该文就阿美替尼的作用机制、药效学、药动学、临床研究及联合治疗作一综述,以期为临床合理用药提供参考。

, authors=付裕豪1, 2, 荀雪姣1, 2, 何雪茹1, 2, 付冉1, 2, 崔艳军1, 2, 董占军2, *, authorsList=付裕豪, 荀雪姣, 何雪茹, 付冉, 崔艳军, 董占军, authorCompany=null, correspAuthors=董占军, authorNote=

付裕豪,硕士研究生,研究方向:临床药学。

, correspAuthorsNote=
董占军,硕士,主任药师,研究方向:临床药学、医院药学管理。
, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=yyBuim3d7bio07dDBNgnUg==, magXml=mmmSdHjt8dl6nE/cy1JsLw==, pdfUrl=null, pdf=qPBoky2kIpISO145K5C3mg==, pdfFileSize=1853871, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=7c8LOcH+XmX3f+QbRvY1Tg==, mapNumber=null, fund=null)}, authors=[Author(id=1330225288190997234, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225287033369318, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1330225288295854837, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225287033369318, authorId=1330225288190997234, language=EN, stringName=Yuhao FU, firstName=Yuhao, middleName=null, lastName=FU, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, address=1.Graduate School of Hebei Medical University, Shijiazhuang 050017, Hebei Province, China
2.Department of Pharmacy, Hebei General Hospital, Shijiazhuang 050051, Hebei Province, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330225288375546614, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225287033369318, authorId=1330225288190997234, language=CN, stringName=付裕豪, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, address=1.河北医科大学研究生学院,河北 石家庄 050017
2.河北省人民医院药学部,河北 石家庄 050051, bio={"content":"

付裕豪,硕士研究生,研究方向:临床药学。

"}, bioImg=null, bioContent=

付裕豪,硕士研究生,研究方向:临床药学。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330225287964504811, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225287033369318, xref=1., ext=[AuthorCompanyExt(id=1330225287977087724, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225287033369318, companyId=1330225287964504811, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.Graduate School of Hebei Medical University, Shijiazhuang 050017, Hebei Province, China), AuthorCompanyExt(id=1330225287989670637, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225287033369318, companyId=1330225287964504811, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.河北医科大学研究生学院,河北 石家庄 050017)]), AuthorCompany(id=1330225288069362414, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225287033369318, xref=2., ext=[AuthorCompanyExt(id=1330225288077751023, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225287033369318, companyId=1330225288069362414, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Department of Pharmacy, Hebei General Hospital, Shijiazhuang 050051, Hebei Province, China), AuthorCompanyExt(id=1330225288090333936, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225287033369318, companyId=1330225288069362414, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.河北省人民医院药学部,河北 石家庄 050051)])]), Author(id=1330225288451044088, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225287033369318, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1330225288555901691, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225287033369318, authorId=1330225288451044088, language=EN, stringName=Xuejiao XUN, firstName=Xuejiao, middleName=null, lastName=XUN, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, address=1.Graduate School of Hebei Medical University, Shijiazhuang 050017, Hebei Province, China
2.Department of Pharmacy, Hebei General Hospital, Shijiazhuang 050051, Hebei Province, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330225288639787772, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225287033369318, authorId=1330225288451044088, language=CN, stringName=荀雪姣, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, address=1.河北医科大学研究生学院,河北 石家庄 050017
2.河北省人民医院药学部,河北 石家庄 050051, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330225287964504811, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225287033369318, xref=1., ext=[AuthorCompanyExt(id=1330225287977087724, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225287033369318, companyId=1330225287964504811, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.Graduate School of Hebei Medical University, Shijiazhuang 050017, Hebei Province, China), AuthorCompanyExt(id=1330225287989670637, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225287033369318, companyId=1330225287964504811, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.河北医科大学研究生学院,河北 石家庄 050017)]), AuthorCompany(id=1330225288069362414, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225287033369318, xref=2., ext=[AuthorCompanyExt(id=1330225288077751023, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225287033369318, companyId=1330225288069362414, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Department of Pharmacy, Hebei General Hospital, Shijiazhuang 050051, Hebei Province, China), AuthorCompanyExt(id=1330225288090333936, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225287033369318, companyId=1330225288069362414, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.河北省人民医院药学部,河北 石家庄 050051)])]), Author(id=1330225288732062464, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225287033369318, orderNo=2, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1330225288815948547, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225287033369318, authorId=1330225288732062464, language=EN, stringName=Xueru HE, firstName=Xueru, middleName=null, lastName=HE, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, address=1.Graduate School of Hebei Medical University, Shijiazhuang 050017, Hebei Province, China
2.Department of Pharmacy, Hebei General Hospital, Shijiazhuang 050051, Hebei Province, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330225288878863108, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225287033369318, authorId=1330225288732062464, language=CN, stringName=何雪茹, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, address=1.河北医科大学研究生学院,河北 石家庄 050017
2.河北省人民医院药学部,河北 石家庄 050051, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330225287964504811, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225287033369318, xref=1., ext=[AuthorCompanyExt(id=1330225287977087724, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225287033369318, companyId=1330225287964504811, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.Graduate School of Hebei Medical University, Shijiazhuang 050017, Hebei Province, China), AuthorCompanyExt(id=1330225287989670637, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225287033369318, companyId=1330225287964504811, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.河北医科大学研究生学院,河北 石家庄 050017)]), AuthorCompany(id=1330225288069362414, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225287033369318, xref=2., ext=[AuthorCompanyExt(id=1330225288077751023, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225287033369318, companyId=1330225288069362414, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Department of Pharmacy, Hebei General Hospital, Shijiazhuang 050051, Hebei Province, China), AuthorCompanyExt(id=1330225288090333936, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225287033369318, companyId=1330225288069362414, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.河北省人民医院药学部,河北 石家庄 050051)])]), Author(id=1330225288945971974, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225287033369318, orderNo=3, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1330225289029858057, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225287033369318, authorId=1330225288945971974, language=EN, stringName=Ran FU, firstName=Ran, middleName=null, lastName=FU, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, address=1.Graduate School of Hebei Medical University, Shijiazhuang 050017, Hebei Province, China
2.Department of Pharmacy, Hebei General Hospital, Shijiazhuang 050051, Hebei Province, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330225289096966922, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225287033369318, authorId=1330225288945971974, language=CN, stringName=付冉, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, address=1.河北医科大学研究生学院,河北 石家庄 050017
2.河北省人民医院药学部,河北 石家庄 050051, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330225287964504811, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225287033369318, xref=1., ext=[AuthorCompanyExt(id=1330225287977087724, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225287033369318, companyId=1330225287964504811, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.Graduate School of Hebei Medical University, Shijiazhuang 050017, Hebei Province, China), AuthorCompanyExt(id=1330225287989670637, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225287033369318, companyId=1330225287964504811, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.河北医科大学研究生学院,河北 石家庄 050017)]), AuthorCompany(id=1330225288069362414, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225287033369318, xref=2., ext=[AuthorCompanyExt(id=1330225288077751023, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225287033369318, companyId=1330225288069362414, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Department of Pharmacy, Hebei General Hospital, Shijiazhuang 050051, Hebei Province, China), AuthorCompanyExt(id=1330225288090333936, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225287033369318, companyId=1330225288069362414, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.河北省人民医院药学部,河北 石家庄 050051)])]), Author(id=1330225289164075788, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225287033369318, orderNo=4, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1330225289268933391, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225287033369318, authorId=1330225289164075788, language=EN, stringName=Yanjun CUI, firstName=Yanjun, middleName=null, lastName=CUI, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, address=1.Graduate School of Hebei Medical University, Shijiazhuang 050017, Hebei Province, China
2.Department of Pharmacy, Hebei General Hospital, Shijiazhuang 050051, Hebei Province, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330225289352819472, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225287033369318, authorId=1330225289164075788, language=CN, stringName=崔艳军, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, address=1.河北医科大学研究生学院,河北 石家庄 050017
2.河北省人民医院药学部,河北 石家庄 050051, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330225287964504811, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225287033369318, xref=1., ext=[AuthorCompanyExt(id=1330225287977087724, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225287033369318, companyId=1330225287964504811, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.Graduate School of Hebei Medical University, Shijiazhuang 050017, Hebei Province, China), AuthorCompanyExt(id=1330225287989670637, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225287033369318, companyId=1330225287964504811, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.河北医科大学研究生学院,河北 石家庄 050017)]), AuthorCompany(id=1330225288069362414, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225287033369318, xref=2., ext=[AuthorCompanyExt(id=1330225288077751023, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225287033369318, companyId=1330225288069362414, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Department of Pharmacy, Hebei General Hospital, Shijiazhuang 050051, Hebei Province, China), AuthorCompanyExt(id=1330225288090333936, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225287033369318, companyId=1330225288069362414, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.河北省人民医院药学部,河北 石家庄 050051)])]), Author(id=1330225290963432212, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225287033369318, orderNo=5, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1330225291059901206, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225287033369318, authorId=1330225290963432212, language=EN, stringName=Zhanjun DONG, firstName=Zhanjun, middleName=null, lastName=DONG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, *, address=2.Department of Pharmacy, Hebei General Hospital, Shijiazhuang 050051, Hebei Province, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330225291135398679, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225287033369318, authorId=1330225290963432212, language=CN, stringName=董占军, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, *, address=2.河北省人民医院药学部,河北 石家庄 050051, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330225288069362414, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225287033369318, xref=2., ext=[AuthorCompanyExt(id=1330225288077751023, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225287033369318, companyId=1330225288069362414, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Department of Pharmacy, Hebei General Hospital, Shijiazhuang 050051, Hebei Province, China), AuthorCompanyExt(id=1330225288090333936, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225287033369318, companyId=1330225288069362414, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.河北省人民医院药学部,河北 石家庄 050051)])])], keywords=[Keyword(id=1330225291252839192, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225287033369318, language=EN, orderNo=1, keyword=almonertinib), Keyword(id=1330225291366085401, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225287033369318, language=EN, orderNo=2, keyword=non-small cell lung cancer), Keyword(id=1330225291428999963, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225287033369318, language=EN, orderNo=3, keyword=epidermal growth factor receptor tyrosine kinase inhibitor), Keyword(id=1330225291647103773, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225287033369318, language=CN, orderNo=1, keyword=阿美替尼), Keyword(id=1330225291743572766, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225287033369318, language=CN, orderNo=2, keyword=非小细胞肺癌), Keyword(id=1330225291819070239, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225287033369318, language=CN, orderNo=3, keyword=表皮生长因子受体酪氨酸激酶抑制剂)], refs=[Reference(id=1330225292121060129, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225287033369318, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[1], rfOrder=0, authorNames=null, journalName=null, refType=null, unstructuredReference=Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019[J]. CA Cancer J Clin, 2019, 69(1): 7-34., articleTitle=null, refAbstract=null), Reference(id=1330225292188168994, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225287033369318, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[2], rfOrder=1, authorNames=null, journalName=null, refType=null, unstructuredReference=Lee DH. Treatments for EGFR-mutant non-small cell lung cancer (NSCLC): the road to a success, paved with failures[J]. Pharmacol Ther, 2017, 174: 1-21., articleTitle=null, refAbstract=null), Reference(id=1330225292280443683, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225287033369318, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[3], rfOrder=2, authorNames=null, journalName=null, refType=null, unstructuredReference=Zhang YL, Yuan JQ, Wang KF, et al. The prevalence of EGFR mutation in patients with non-small cell lung cancer: a systematic review and meta-analysis[J]. Oncotarget, 2016, 7(48): 78985-78993., articleTitle=null, refAbstract=null), Reference(id=1330225292339163940, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225287033369318, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[4], rfOrder=3, authorNames=null, journalName=null, refType=null, unstructuredReference=Harrison PT, Vyse S, Huang PH. Rare epidermal growth factor receptor (EGFR) mutations in non-small cell lung cancer[J]. Semin Cancer Biol, 2020, 61: 167-179., articleTitle=null, refAbstract=null), Reference(id=1330225292418855717, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225287033369318, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[5], rfOrder=4, authorNames=null, journalName=null, refType=null, unstructuredReference=Minari R, Bordi P, Tiseo M. Third-generation epidermal growth factor receptor-tyrosine kinase inhibitors in T790M-positive non-small cell lung cancer: review on emerged mechanisms of resistance[J]. Transl Lung Cancer Res, 2016, 5(6): 695-708., articleTitle=null, refAbstract=null), Reference(id=1330225292485964582, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225287033369318, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[6], rfOrder=5, authorNames=null, journalName=null, refType=null, unstructuredReference=Jia Y, Yun Ch, Park E, et al. Overcoming EGFR(T790M) and EGFR(C797S) resistance with mutant-selective allosteric inhibitors[J]. Nature, 2016, 534(7605): 129-132., articleTitle=null, refAbstract=null), Reference(id=1330225292553073447, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225287033369318, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[7], rfOrder=6, authorNames=null, journalName=null, refType=null, unstructuredReference=Chen HY, Liu CH, Chang YH, et al. EGFR-activating mutations, DNA copy number abundance of ErbB family, and prognosis in lung adenocarcinoma[J]. Oncotarget, 2016, 7(8): 9017-9025., articleTitle=null, refAbstract=null), Reference(id=1330225292624376616, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225287033369318, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[8], rfOrder=7, authorNames=null, journalName=null, refType=null, unstructuredReference=Ge X, Zhang Y, Huang F, et al. EGFR tyrosine kinase inhibitor almonertinib induces apoptosis and autophagy mediated by reactive oxygen species in non-small cell lung cancer cells[J]. Hum Exp Toxicol, 2021, 40(Suppl 12): 9603271211030554., articleTitle=null, refAbstract=null), Reference(id=1330225292687291177, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225287033369318, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[9], rfOrder=8, authorNames=null, journalName=null, refType=null, unstructuredReference=Santarpia M, Liguori A, Karachaliou N, et al. Osimertinib in the treatment of non-small-cell lung cancer: design, development and place in therapy[J]. Lung Cancer (Auckl), 2017, 8: 109-125., articleTitle=null, refAbstract=null), Reference(id=1330225292758594346, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225287033369318, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[10], rfOrder=9, authorNames=null, journalName=null, refType=null, unstructuredReference=中国医师协会肿瘤医师分会, 中国医疗保健国际交流促进会肿瘤内科分会. Ⅳ期原发性肺癌中国治疗指南(2021年版)[J]. 中华肿瘤杂志, 2021, 43(1): 39-59., articleTitle=null, refAbstract=null), Reference(id=1330225292821508907, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225287033369318, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[11], rfOrder=10, authorNames=null, journalName=null, refType=null, unstructuredReference=中国医师协会肿瘤医师分会, 中国医疗保健国际交流促进会肿瘤内科分会. 肺癌脑转移中国治疗指南(2021年版)[J]. 中华肿瘤杂志, 2021, 43(3): 269-281., articleTitle=null, refAbstract=null), Reference(id=1330225292880229164, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225287033369318, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[12], rfOrder=11, authorNames=null, journalName=null, refType=null, unstructuredReference=Nagasaka M, Zhu VW, Lim SM, et al. Beyond osimertinib: the development of third-generation EGFR tyrosine kinase inhibitors for advanced EGFR+NSCLC[J]. Thorac Oncol, 2021, 16(5): 740-763., articleTitle=null, refAbstract=null), Reference(id=1330225292947338029, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225287033369318, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[13], rfOrder=12, authorNames=null, journalName=null, refType=null, unstructuredReference=Bao R, Gao P, Zhang F, et al. Discovery of a third-generation EGFR inhibitor, which is highly selective and potent against both resistant and activating EGFR mutations for NSCLC therapy[J]. AACR Annual Meeting, 2016, 76(Suppl 14): 3063., articleTitle=null, refAbstract=null), Reference(id=1330225293006058286, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225287033369318, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[14], rfOrder=13, authorNames=null, journalName=null, refType=null, unstructuredReference=Zhang Y, Zhang Y, Niu W, et al. Experimental study of almonertinib crossing the blood-brain barrier in egfr-mutant NSCLC brain metastasis and spinal cord metastasis models[J]. Front Pharmacol, 2021, 12: 750031., articleTitle=null, refAbstract=null), Reference(id=1330225293064778543, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225287033369318, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[15], rfOrder=14, authorNames=null, journalName=null, refType=null, unstructuredReference=Zhou C, Xie L, Liu W, et al. Absorption, metabolism, excretion, and safety of [14C] almonertinib in healthy Chinese subjects[J]. Ann Transl Med, 2021, 9(10): 867., articleTitle=null, refAbstract=null), Reference(id=1330225293127693104, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225287033369318, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[16], rfOrder=15, authorNames=null, journalName=null, refType=null, unstructuredReference=Liu L, Li W, Yang L, et al. Itraconazole and rifampicin, as CYP3A modulators but not P-gp modulators, affect the pharmacokinetics of almonertinib and active metabolite HAS-719 in healthy volunteers[J]. Acta Pharmacol Sin, 2021, doi: 10.1038/s41401-021-00710-8., articleTitle=null, refAbstract=null), Reference(id=1330225293194801969, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225287033369318, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[17], rfOrder=16, authorNames=null, journalName=null, refType=null, unstructuredReference=Wu CP, Hung TH, Lusvarghi S, et al. The third-generation EGFR inhibitor almonertinib (HS-10296) resensitizes ABCB1-overexpressing multidrug-resistant cancer cells to chemotherapeutic drugs[J]. Biochem Pharmacol, 2021, 188: 114516., articleTitle=null, refAbstract=null), Reference(id=1330225293257716530, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225287033369318, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[18], rfOrder=17, authorNames=null, journalName=null, refType=null, unstructuredReference=Yang JCH, Camidge DR, Yang CT, et al. Safety, efficacy, and pharmacokinetics of almonertinib (HS-10296) in pretreated patients with EGFR-mutated advanced NSCLC: a multicenter, open-label, phase 1 trial[J]. J Thor Oncol, 2020, 15(12): 1907-1918., articleTitle=null, refAbstract=null), Reference(id=1330225293333214003, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225287033369318, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[19], rfOrder=18, authorNames=null, journalName=null, refType=null, unstructuredReference=Lu S, Camidge DR, Yang CT, et al. The third generation irreversible EGFR inhibitor HS-10296 in advanced non-small cell lung cancer patients[J]. Thorac Oncol, 2018, 13(10): S485., articleTitle=null, refAbstract=null), Reference(id=1330225293396128564, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225287033369318, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[20], rfOrder=19, authorNames=null, journalName=null, refType=null, unstructuredReference=Lu S, Wang Q, Zhang G, et al. The third generation EGFR inhibitor (EGFR-TKI) HS-10296 in advanced NSCLC patients with resistance to first generation EGFR-TKI[J]. J Thor Oncol, 2019, 14(10): S208-S209., articleTitle=null, refAbstract=null), Reference(id=1330225293454848821, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225287033369318, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[21], rfOrder=20, authorNames=null, journalName=null, refType=null, unstructuredReference=Lu S, Wang Q, Zhang G, et al. Efficacy of aumolertinib (HS-10296) in patients with advanced EGFR T790M+NSCLC: updated post NMPA-approval results from the APOLLO registrational trial[J]. J Thorac Oncol, 2021, 17(3): 411-422., articleTitle=null, refAbstract=null), Reference(id=1330225293513569078, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225287033369318, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[22], rfOrder=21, authorNames=null, journalName=null, refType=null, unstructuredReference=Lu S, Dong XR, Jian H, et al. Randomized phase Ⅲ trial of aumolertinib (HS-10296, Au) versus gefitinib (G) as first-line treatment of patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) and EGFR exon 19 del or L858R mutations (EGFRm)[J]. ASCO, 2021, 39(Suppl 15): 9013., articleTitle=null, refAbstract=null), Reference(id=1330225293572289335, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225287033369318, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[23], rfOrder=22, authorNames=null, journalName=null, refType=null, unstructuredReference=Lamb YN. Osimertinib: a review in previously untreated, EGFR mutation-positive, advanced NSCLC[J]. Target Oncol, 2021, 16(5): 687-695., articleTitle=null, refAbstract=null), Reference(id=1330225293626815288, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225287033369318, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[24], rfOrder=23, authorNames=null, journalName=null, refType=null, unstructuredReference=Cheng Y, He Y, Li W, et al. Osimertinib versus comparator EGFR TKI as first-line treatment for EGFR-Mutated advanced NSCLC: FLAURA China, a randomized study[J]. Target Oncol, 2021, 16(2): 165-176., articleTitle=null, refAbstract=null), Reference(id=1330225293702312761, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225287033369318, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[25], rfOrder=24, authorNames=null, journalName=null, refType=null, unstructuredReference=仲佳. 《CSCO非小细胞肺癌诊疗指南2021》更新要点解读[J]. 实用肿瘤杂志, 2022, 37(1): 8-15., articleTitle=null, refAbstract=null), Reference(id=1330225293761033018, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225287033369318, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[26], rfOrder=25, authorNames=null, journalName=null, refType=null, unstructuredReference=Wu L, Zhong W, Li A, et al. Successful treatment of EGFR T790M-mutant non-small cell lung cancer with almonertinib after osimertinib-induced interstitial lung disease: a case report and literature review[J]. Ann Transl Med, 2021, 9(11): 950., articleTitle=null, refAbstract=null), Reference(id=1330225293844919099, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225287033369318, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[27], rfOrder=26, authorNames=null, journalName=null, refType=null, unstructuredReference=Zhang M, Quan H, Fu L, et al. Third-generation EGFR inhibitor HS-10296 in combination with famitinib, a multi-targeted tyrosine kinase inhibitor, exerts synergistic antitumor effects through enhanced inhibition of downstream signaling in EGFR-mutant non-small cell lung cancer cells[J]. Thorac Cancer, 2021, 12(8): 1210-1218., articleTitle=null, refAbstract=null), Reference(id=1330225295468114748, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225287033369318, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[28], rfOrder=27, authorNames=null, journalName=null, refType=null, unstructuredReference=Liu Y, Ge X, Pang J, et al. Restricting glutamine uptake enhances NSCLC sensitivity to third-generation EGFR-TKI almonertinib[J]. Front Pharmacol, 2021, 12: 671328., articleTitle=null, refAbstract=null), Reference(id=1330225295547806525, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225287033369318, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[29], rfOrder=28, authorNames=null, journalName=null, refType=null, unstructuredReference=Zhu L, Zou C, Zhang Z, et al. Thoracic radiotherapy and concurrent almonertinib for unresectable stage Ⅲ EGFR-mutated non-small-cell lung cancer: a phase 2 study[J]. BMC Cancer, 2021, 21(1): 511., articleTitle=null, refAbstract=null), Reference(id=1330225295614915390, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225287033369318, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[30], rfOrder=29, authorNames=null, journalName=null, refType=null, unstructuredReference=Oxnard GR, Hu Y, Mileham KF, et al. Assessment of resistance mechanisms and clinical implications in patients with EGFR T790M-positive lung cancer and acquired resistance to osimertinib[J]. JAMA Oncol, 2018, 4(11): 1527-1534., articleTitle=null, refAbstract=null)], funds=[Fund(id=1330225291970065184, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225287033369318, awardId=20210037, language=CN, fundingSource=中西药合用代谢性相互作用及其机制研究(20210037), fundOrder=null, country=null)], companyList=[AuthorCompany(id=1330225287964504811, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225287033369318, xref=1., ext=[AuthorCompanyExt(id=1330225287977087724, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225287033369318, companyId=1330225287964504811, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.Graduate School of Hebei Medical University, Shijiazhuang 050017, Hebei Province, China), AuthorCompanyExt(id=1330225287989670637, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225287033369318, companyId=1330225287964504811, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.河北医科大学研究生学院,河北 石家庄 050017)]), AuthorCompany(id=1330225288069362414, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225287033369318, xref=2., ext=[AuthorCompanyExt(id=1330225288077751023, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225287033369318, companyId=1330225288069362414, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Department of Pharmacy, Hebei General Hospital, Shijiazhuang 050051, Hebei Province, China), AuthorCompanyExt(id=1330225288090333936, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225287033369318, companyId=1330225288069362414, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.河北省人民医院药学部,河北 石家庄 050051)])], figs=null, attaches=null, journal=Journal(id=1319689997550452896, delFlag=0, nameCn=世界临床药物, nameEn=World Clinical Drug, nameHistory1=null, nameHistory2=null, issn=1672-9188, eissn=null, cn=31-1939/R, coden=SLYHAA, periodic=0, language=CN, oaType=null, ccby=null, superviseOffice=null, ownerOffice=null, pubOffice=null, editorOffice=null, officeType=null, aims=null, clcCode=null, officeProv=null, officeCity=null, officeAddr=null, officeZip=null, officeEmail=null, officePhone=null, editDirector=null, officeDirector=null, officeDirectorPhone=null, officeStaffNum=null, officeEmpNum=null, coverPicUrl=9c6IkcJKa1cF20h1u6lJeQ==, journalPrice=null, startedYear=null, abbrevIsoEn=World Clinical Drug, journalRemark=null, publicationField=null, createdTime=1792568214072, updatedTime=1792747519563, createdBy=18614031015, updatedBy=13701087609, firstLetterCn=S, firstLetterEn=S, subjectCode=Medical and Pharmaceutical Sciences, subjectName=null, subjectCodeEn=Medical and Pharmaceutical Sciences, subjectNameEn=null, picCn=9c6IkcJKa1cF20h1u6lJeQ==, picEn=MRqUlTwfL6oqIHNy7eyFZQ==, jcr=null, cjcr=null, exts=[JournalExt(id=1320442059660570919, language=CN, name=世界临床药物, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747519650, updatedTime=1792747519650, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=http://www.jwph.com.cn/journalx_sjlcyw/authorLogOn.action, submissionEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorLogOn.action, submissionReviewUrl=http://www.jwph.com.cn/journalx_sjlcyw/expertLogOn.action, submissionCeEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorInChiefLogOn.action, submissionAeEditorUrl=, option={"copyright":""}), JournalExt(id=1320442059723485480, language=EN, name=World Clinical Drug, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747519665, updatedTime=1792747519665, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=http://www.jwph.com.cn/journalx_sjlcyw/authorLogOn.action, submissionEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorLogOn.action, submissionReviewUrl=http://www.jwph.com.cn/journalx_sjlcyw/expertLogOn.action, submissionCeEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorInChiefLogOn.action, submissionAeEditorUrl=, option={"copyright":""})], databaseList=null, tenantJournalId=1319690329412173987, websiteList=[Website(id=1321427104911179915, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690329412173987, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/sjlcyw/CN, language=CN, createTime=1792982372739, createBy=18614031015, updateTime=1792982514949, updateBy=18614031015, name=世界临床药物-中文, tplId=1146099689490845704, title=世界临床药物, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428428256031726, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=articleTextType, value=kx, createTime=1792982688249, updateTime=1792982688249, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428193117163, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=banner, value=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/file/pic?fileId=RR/csUBcM48ejcuaaK5s0g==, createTime=1792982688234, updateTime=1792982688234, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428302169073, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=grayFlag, value=0, createTime=1792982688260, updateTime=1792982688260, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428172145642, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=logo, value=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/file/pic?fileId=yyY2emcxcV1CfIeK9tH8ZA==, createTime=1792982688229, updateTime=1792982688229, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428327334899, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=minRunFlag, value=0, createTime=1792982688266, updateTime=1792982688266, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428226671597, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/file/pic, createTime=1792982688242, updateTime=1792982688242, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428314751986, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=silenceFlag, value=0, createTime=1792982688263, updateTime=1792982688263, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428209894380, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_cn_619/, createTime=1792982688238, updateTime=1792982688238, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428268614639, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=themeColor, value=null, createTime=1792982688252, updateTime=1792982688252, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428289586160, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982688257, updateTime=1792982688257, creator=18614031015, updator=18614031015)]), Website(id=1321427104990871693, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690329412173987, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/sjlcyw/EN, language=EN, createTime=1792982372758, createBy=18614031015, updateTime=1792982556355, updateBy=18614031015, name=世界临床药物-英文, tplId=1146101810881728533, title=World Clinical Drug, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428446820021244, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=articleTextType, value=kx, createTime=1792982692675, updateTime=1792982692675, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446757106681, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=banner, value=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/file/pic?fileId=RR/csUBcM48ejcuaaK5s0g==, createTime=1792982692660, updateTime=1792982692660, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447109428223, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=grayFlag, value=0, createTime=1792982692744, updateTime=1792982692744, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446736135160, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=logo, value=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/file/pic?fileId=yyY2emcxcV1CfIeK9tH8ZA==, createTime=1792982692655, updateTime=1792982692655, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447142981632, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=minRunFlag, value=0, createTime=1792982692752, updateTime=1792982692752, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446790661115, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/file/pic, createTime=1792982692668, updateTime=1792982692668, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447130399745, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=silenceFlag, value=0, createTime=1792982692749, updateTime=1792982692749, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446769689594, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_en_623/, createTime=1792982692663, updateTime=1792982692663, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446832604157, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=themeColor, value=null, createTime=1792982692678, updateTime=1792982692678, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447092651006, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982692740, updateTime=1792982692740, creator=18614031015, updator=18614031015)])], journalTitle=世界临床药物, weixinUrl=null, journalUrl=http://www.jwph.com.cn/, iacademicId=null, status=1, seqNo=null, journalTitleEn=World Clinical Drug, journalPhotoCn=9c6IkcJKa1cF20h1u6lJeQ==, journalPhotoEn=MRqUlTwfL6oqIHNy7eyFZQ==, journalFirstLetter=S, journalRecommend=null, journalNew=null, journalCollection=null, jcrJf=null, cjcrJf=null, jcrJfStr=null, cjcrJfStr=null, submissionFirstDecision=null, sciSubjectClassification=null, casSubjectClassification=null, citeScore=null, totalCitationFrequency=null, icpCode=null, psCode=null, advertisingLicenseCode=null, copyrightInformation=null, country=null, option=, provinceCode=null, provinceName=null, collectFlag=false, interPubPlatform=, interPubPlatformUrl=null), detailUrlCn=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/10.13683/j.wph.2022.03.020, detailUrlEn=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/10.13683/j.wph.2022.03.020, pdfUrlCn=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/PDF/10.13683/j.wph.2022.03.020, pdfUrlEn=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/PDF/10.13683/j.wph.2022.03.020, aliStartDate=0, aliEndDate=0, collectionFlag=false, citedCount=null, citedUrl=null, previewStatus=0, delFlag=0, hasFullText=0, orderTime=1646841600000, fullTextJson=null, articleText=null, reference=null)
收藏切换
阿美替尼治疗晚期非小细胞肺癌的研究进展
付裕豪 1, 2 , 荀雪姣 1, 2 , 何雪茹 1, 2 , 付冉 1, 2 , 崔艳军 1, 2 , 董占军 2, *
世界临床药物 | 综述评论 2022,43(3): 325-330
收起
收藏切换
世界临床药物 |综述评论 2022 , 43 (3) : 325 -330
阿美替尼治疗晚期非小细胞肺癌的研究进展
全屏
[Author(id=1330225288190997234, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225287033369318, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1330225288295854837, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225287033369318, authorId=1330225288190997234, language=EN, stringName=Yuhao FU, firstName=Yuhao, middleName=null, lastName=FU, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, address=1.Graduate School of Hebei Medical University, Shijiazhuang 050017, Hebei Province, China
2.Department of Pharmacy, Hebei General Hospital, Shijiazhuang 050051, Hebei Province, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330225288375546614, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225287033369318, authorId=1330225288190997234, language=CN, stringName=付裕豪, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, address=1.河北医科大学研究生学院,河北 石家庄 050017
2.河北省人民医院药学部,河北 石家庄 050051, bio={"content":"

付裕豪,硕士研究生,研究方向:临床药学。

"}, bioImg=null, bioContent=

付裕豪,硕士研究生,研究方向:临床药学。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330225287964504811, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225287033369318, xref=1., ext=[AuthorCompanyExt(id=1330225287977087724, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225287033369318, companyId=1330225287964504811, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.Graduate School of Hebei Medical University, Shijiazhuang 050017, Hebei Province, China), AuthorCompanyExt(id=1330225287989670637, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225287033369318, companyId=1330225287964504811, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.河北医科大学研究生学院,河北 石家庄 050017)]), AuthorCompany(id=1330225288069362414, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225287033369318, xref=2., ext=[AuthorCompanyExt(id=1330225288077751023, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225287033369318, companyId=1330225288069362414, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Department of Pharmacy, Hebei General Hospital, Shijiazhuang 050051, Hebei Province, China), AuthorCompanyExt(id=1330225288090333936, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225287033369318, companyId=1330225288069362414, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.河北省人民医院药学部,河北 石家庄 050051)])]), Author(id=1330225288451044088, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225287033369318, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1330225288555901691, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225287033369318, authorId=1330225288451044088, language=EN, stringName=Xuejiao XUN, firstName=Xuejiao, middleName=null, lastName=XUN, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, address=1.Graduate School of Hebei Medical University, Shijiazhuang 050017, Hebei Province, China
2.Department of Pharmacy, Hebei General Hospital, Shijiazhuang 050051, Hebei Province, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330225288639787772, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225287033369318, authorId=1330225288451044088, language=CN, stringName=荀雪姣, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, address=1.河北医科大学研究生学院,河北 石家庄 050017
2.河北省人民医院药学部,河北 石家庄 050051, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330225287964504811, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225287033369318, xref=1., ext=[AuthorCompanyExt(id=1330225287977087724, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225287033369318, companyId=1330225287964504811, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.Graduate School of Hebei Medical University, Shijiazhuang 050017, Hebei Province, China), AuthorCompanyExt(id=1330225287989670637, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225287033369318, companyId=1330225287964504811, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.河北医科大学研究生学院,河北 石家庄 050017)]), AuthorCompany(id=1330225288069362414, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225287033369318, xref=2., ext=[AuthorCompanyExt(id=1330225288077751023, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225287033369318, companyId=1330225288069362414, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Department of Pharmacy, Hebei General Hospital, Shijiazhuang 050051, Hebei Province, China), AuthorCompanyExt(id=1330225288090333936, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225287033369318, companyId=1330225288069362414, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.河北省人民医院药学部,河北 石家庄 050051)])]), Author(id=1330225288732062464, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225287033369318, orderNo=2, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1330225288815948547, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225287033369318, authorId=1330225288732062464, language=EN, stringName=Xueru HE, firstName=Xueru, middleName=null, lastName=HE, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, address=1.Graduate School of Hebei Medical University, Shijiazhuang 050017, Hebei Province, China
2.Department of Pharmacy, Hebei General Hospital, Shijiazhuang 050051, Hebei Province, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330225288878863108, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225287033369318, authorId=1330225288732062464, language=CN, stringName=何雪茹, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, address=1.河北医科大学研究生学院,河北 石家庄 050017
2.河北省人民医院药学部,河北 石家庄 050051, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330225287964504811, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225287033369318, xref=1., ext=[AuthorCompanyExt(id=1330225287977087724, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225287033369318, companyId=1330225287964504811, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.Graduate School of Hebei Medical University, Shijiazhuang 050017, Hebei Province, China), AuthorCompanyExt(id=1330225287989670637, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225287033369318, companyId=1330225287964504811, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.河北医科大学研究生学院,河北 石家庄 050017)]), AuthorCompany(id=1330225288069362414, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225287033369318, xref=2., ext=[AuthorCompanyExt(id=1330225288077751023, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225287033369318, companyId=1330225288069362414, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Department of Pharmacy, Hebei General Hospital, Shijiazhuang 050051, Hebei Province, China), AuthorCompanyExt(id=1330225288090333936, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225287033369318, companyId=1330225288069362414, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.河北省人民医院药学部,河北 石家庄 050051)])]), Author(id=1330225288945971974, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225287033369318, orderNo=3, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1330225289029858057, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225287033369318, authorId=1330225288945971974, language=EN, stringName=Ran FU, firstName=Ran, middleName=null, lastName=FU, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, address=1.Graduate School of Hebei Medical University, Shijiazhuang 050017, Hebei Province, China
2.Department of Pharmacy, Hebei General Hospital, Shijiazhuang 050051, Hebei Province, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330225289096966922, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225287033369318, authorId=1330225288945971974, language=CN, stringName=付冉, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, address=1.河北医科大学研究生学院,河北 石家庄 050017
2.河北省人民医院药学部,河北 石家庄 050051, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330225287964504811, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225287033369318, xref=1., ext=[AuthorCompanyExt(id=1330225287977087724, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225287033369318, companyId=1330225287964504811, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.Graduate School of Hebei Medical University, Shijiazhuang 050017, Hebei Province, China), AuthorCompanyExt(id=1330225287989670637, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225287033369318, companyId=1330225287964504811, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.河北医科大学研究生学院,河北 石家庄 050017)]), AuthorCompany(id=1330225288069362414, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225287033369318, xref=2., ext=[AuthorCompanyExt(id=1330225288077751023, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225287033369318, companyId=1330225288069362414, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Department of Pharmacy, Hebei General Hospital, Shijiazhuang 050051, Hebei Province, China), AuthorCompanyExt(id=1330225288090333936, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225287033369318, companyId=1330225288069362414, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.河北省人民医院药学部,河北 石家庄 050051)])]), Author(id=1330225289164075788, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225287033369318, orderNo=4, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1330225289268933391, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225287033369318, authorId=1330225289164075788, language=EN, stringName=Yanjun CUI, firstName=Yanjun, middleName=null, lastName=CUI, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, address=1.Graduate School of Hebei Medical University, Shijiazhuang 050017, Hebei Province, China
2.Department of Pharmacy, Hebei General Hospital, Shijiazhuang 050051, Hebei Province, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330225289352819472, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225287033369318, authorId=1330225289164075788, language=CN, stringName=崔艳军, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, address=1.河北医科大学研究生学院,河北 石家庄 050017
2.河北省人民医院药学部,河北 石家庄 050051, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330225287964504811, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225287033369318, xref=1., ext=[AuthorCompanyExt(id=1330225287977087724, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225287033369318, companyId=1330225287964504811, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.Graduate School of Hebei Medical University, Shijiazhuang 050017, Hebei Province, China), AuthorCompanyExt(id=1330225287989670637, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225287033369318, companyId=1330225287964504811, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.河北医科大学研究生学院,河北 石家庄 050017)]), AuthorCompany(id=1330225288069362414, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225287033369318, xref=2., ext=[AuthorCompanyExt(id=1330225288077751023, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225287033369318, companyId=1330225288069362414, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Department of Pharmacy, Hebei General Hospital, Shijiazhuang 050051, Hebei Province, China), AuthorCompanyExt(id=1330225288090333936, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225287033369318, companyId=1330225288069362414, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.河北省人民医院药学部,河北 石家庄 050051)])]), Author(id=1330225290963432212, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225287033369318, orderNo=5, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1330225291059901206, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225287033369318, authorId=1330225290963432212, language=EN, stringName=Zhanjun DONG, firstName=Zhanjun, middleName=null, lastName=DONG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, *, address=2.Department of Pharmacy, Hebei General Hospital, Shijiazhuang 050051, Hebei Province, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330225291135398679, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225287033369318, authorId=1330225290963432212, language=CN, stringName=董占军, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, *, address=2.河北省人民医院药学部,河北 石家庄 050051, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330225288069362414, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225287033369318, xref=2., ext=[AuthorCompanyExt(id=1330225288077751023, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225287033369318, companyId=1330225288069362414, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Department of Pharmacy, Hebei General Hospital, Shijiazhuang 050051, Hebei Province, China), AuthorCompanyExt(id=1330225288090333936, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225287033369318, companyId=1330225288069362414, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.河北省人民医院药学部,河北 石家庄 050051)])])]
付裕豪1, 2, 荀雪姣1, 2, 何雪茹1, 2, 付冉1, 2, 崔艳军1, 2, 董占军2, *
作者信息
  • 1.河北医科大学研究生学院,河北 石家庄 050017
  • 2.河北省人民医院药学部,河北 石家庄 050051
通讯作者:
董占军,硕士,主任药师,研究方向:临床药学、医院药学管理。
作者简介:

付裕豪,硕士研究生,研究方向:临床药学。

Research progress in almonertinib in the treatment of advanced non-small cell lung cancer
Yuhao FU1, 2, Xuejiao XUN1, 2, Xueru HE1, 2, Ran FU1, 2, Yanjun CUI1, 2, Zhanjun DONG2, *
Affiliations
  • 1.Graduate School of Hebei Medical University, Shijiazhuang 050017, Hebei Province, China
  • 2.Department of Pharmacy, Hebei General Hospital, Shijiazhuang 050051, Hebei Province, China
出版时间: 2022-03-10 doi: 10.13683/j.wph.2022.03.020
文章导航
收藏切换

肺癌(lung cancer)是全球发病率最高的恶性肿瘤之一,也是导致恶性肿瘤相关性死亡的主要原因。其中非小细胞肺癌(non-small cell lung cancer,NSCLC)是主要的肺癌类型,表皮生长因子受体(epidermal growth factor receptor,EGFR)基因突变是其常见的驱动基因。第一、二代表皮生长因子受体酪氨酸激酶抑制剂(epidermal growth factor receptor tyrosine kinase inhibitors,EGFR-TKIs)对EGFR突变阳性的NSCLC疗效确切,但极易出现T790M突变引发的耐药。阿美替尼是我国自主研发的一种新型、不可逆的第3代EGFR-TKI,对EGFR增敏和T790M耐药突变具有高选择性,且具有良好的中枢神经系统活性和耐受性。该文就阿美替尼的作用机制、药效学、药动学、临床研究及联合治疗作一综述,以期为临床合理用药提供参考。

阿美替尼  /  非小细胞肺癌  /  表皮生长因子受体酪氨酸激酶抑制剂

Lung cancer is one of the most common malignant tumors in the world, and it is also the leading cause of cancer-related death. Non-small cell lung cancer (NSCLC) is the main type of lung cancer, and epidermal growth factor receptor (EGFR) gene mutation is a common driving gene for NSCLC. The first and second generation epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) are effective in the treatment of NSCLC with EGFR mutation-positive, but they are prone to drug resistance caused by T790M mutation. Almonertinib is a noval and irreversible third generation EGFR-TKI independently developed in China. It has high selectivity to EGFR sensitization and T790M drug resistance mutation and also has good central nervous system activity and tolerance. In this paper, we reviewed the mechanism of action, pharmacodynamics, pharmacokinetics, clinical research and combination therapy of almonertinib, to provide a reference for clinical application.

almonertinib  /  non-small cell lung cancer  /  epidermal growth factor receptor tyrosine kinase inhibitor
付裕豪, 荀雪姣, 何雪茹, 付冉, 崔艳军, 董占军. 阿美替尼治疗晚期非小细胞肺癌的研究进展. 世界临床药物, 2022 , 43 (3) : 325 -330 . DOI: 10.13683/j.wph.2022.03.020
Yuhao FU, Xuejiao XUN, Xueru HE, Ran FU, Yanjun CUI, Zhanjun DONG. Research progress in almonertinib in the treatment of advanced non-small cell lung cancer[J]. World Clinical Drug, 2022 , 43 (3) : 325 -330 . DOI: 10.13683/j.wph.2022.03.020
  • 中西药合用代谢性相互作用及其机制研究(20210037)
参考文献 引证文献
排序方式:
[1]
Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019[J]. CA Cancer J Clin, 2019, 69(1): 7-34.
[2]
Lee DH. Treatments for EGFR-mutant non-small cell lung cancer (NSCLC): the road to a success, paved with failures[J]. Pharmacol Ther, 2017, 174: 1-21.
[3]
Zhang YL, Yuan JQ, Wang KF, et al. The prevalence of EGFR mutation in patients with non-small cell lung cancer: a systematic review and meta-analysis[J]. Oncotarget, 2016, 7(48): 78985-78993.
[4]
Harrison PT, Vyse S, Huang PH. Rare epidermal growth factor receptor (EGFR) mutations in non-small cell lung cancer[J]. Semin Cancer Biol, 2020, 61: 167-179.
[5]
Minari R, Bordi P, Tiseo M. Third-generation epidermal growth factor receptor-tyrosine kinase inhibitors in T790M-positive non-small cell lung cancer: review on emerged mechanisms of resistance[J]. Transl Lung Cancer Res, 2016, 5(6): 695-708.
[6]
Jia Y, Yun Ch, Park E, et al. Overcoming EGFR(T790M) and EGFR(C797S) resistance with mutant-selective allosteric inhibitors[J]. Nature, 2016, 534(7605): 129-132.
[7]
Chen HY, Liu CH, Chang YH, et al. EGFR-activating mutations, DNA copy number abundance of ErbB family, and prognosis in lung adenocarcinoma[J]. Oncotarget, 2016, 7(8): 9017-9025.
[8]
Ge X, Zhang Y, Huang F, et al. EGFR tyrosine kinase inhibitor almonertinib induces apoptosis and autophagy mediated by reactive oxygen species in non-small cell lung cancer cells[J]. Hum Exp Toxicol, 2021, 40(Suppl 12): 9603271211030554.
[9]
Santarpia M, Liguori A, Karachaliou N, et al. Osimertinib in the treatment of non-small-cell lung cancer: design, development and place in therapy[J]. Lung Cancer (Auckl), 2017, 8: 109-125.
[10]
中国医师协会肿瘤医师分会, 中国医疗保健国际交流促进会肿瘤内科分会. Ⅳ期原发性肺癌中国治疗指南(2021年版)[J]. 中华肿瘤杂志, 2021, 43(1): 39-59.
[11]
中国医师协会肿瘤医师分会, 中国医疗保健国际交流促进会肿瘤内科分会. 肺癌脑转移中国治疗指南(2021年版)[J]. 中华肿瘤杂志, 2021, 43(3): 269-281.
[12]
Nagasaka M, Zhu VW, Lim SM, et al. Beyond osimertinib: the development of third-generation EGFR tyrosine kinase inhibitors for advanced EGFR+NSCLC[J]. Thorac Oncol, 2021, 16(5): 740-763.
[13]
Bao R, Gao P, Zhang F, et al. Discovery of a third-generation EGFR inhibitor, which is highly selective and potent against both resistant and activating EGFR mutations for NSCLC therapy[J]. AACR Annual Meeting, 2016, 76(Suppl 14): 3063.
[14]
Zhang Y, Zhang Y, Niu W, et al. Experimental study of almonertinib crossing the blood-brain barrier in egfr-mutant NSCLC brain metastasis and spinal cord metastasis models[J]. Front Pharmacol, 2021, 12: 750031.
[15]
Zhou C, Xie L, Liu W, et al. Absorption, metabolism, excretion, and safety of [14C] almonertinib in healthy Chinese subjects[J]. Ann Transl Med, 2021, 9(10): 867.
[16]
Liu L, Li W, Yang L, et al. Itraconazole and rifampicin, as CYP3A modulators but not P-gp modulators, affect the pharmacokinetics of almonertinib and active metabolite HAS-719 in healthy volunteers[J]. Acta Pharmacol Sin, 2021, doi: 10.1038/s41401-021-00710-8.
[17]
Wu CP, Hung TH, Lusvarghi S, et al. The third-generation EGFR inhibitor almonertinib (HS-10296) resensitizes ABCB1-overexpressing multidrug-resistant cancer cells to chemotherapeutic drugs[J]. Biochem Pharmacol, 2021, 188: 114516.
[18]
Yang JCH, Camidge DR, Yang CT, et al. Safety, efficacy, and pharmacokinetics of almonertinib (HS-10296) in pretreated patients with EGFR-mutated advanced NSCLC: a multicenter, open-label, phase 1 trial[J]. J Thor Oncol, 2020, 15(12): 1907-1918.
[19]
Lu S, Camidge DR, Yang CT, et al. The third generation irreversible EGFR inhibitor HS-10296 in advanced non-small cell lung cancer patients[J]. Thorac Oncol, 2018, 13(10): S485.
[20]
Lu S, Wang Q, Zhang G, et al. The third generation EGFR inhibitor (EGFR-TKI) HS-10296 in advanced NSCLC patients with resistance to first generation EGFR-TKI[J]. J Thor Oncol, 2019, 14(10): S208-S209.
[21]
Lu S, Wang Q, Zhang G, et al. Efficacy of aumolertinib (HS-10296) in patients with advanced EGFR T790M+NSCLC: updated post NMPA-approval results from the APOLLO registrational trial[J]. J Thorac Oncol, 2021, 17(3): 411-422.
[22]
Lu S, Dong XR, Jian H, et al. Randomized phase Ⅲ trial of aumolertinib (HS-10296, Au) versus gefitinib (G) as first-line treatment of patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) and EGFR exon 19 del or L858R mutations (EGFRm)[J]. ASCO, 2021, 39(Suppl 15): 9013.
[23]
Lamb YN. Osimertinib: a review in previously untreated, EGFR mutation-positive, advanced NSCLC[J]. Target Oncol, 2021, 16(5): 687-695.
[24]
Cheng Y, He Y, Li W, et al. Osimertinib versus comparator EGFR TKI as first-line treatment for EGFR-Mutated advanced NSCLC: FLAURA China, a randomized study[J]. Target Oncol, 2021, 16(2): 165-176.
[25]
仲佳. 《CSCO非小细胞肺癌诊疗指南2021》更新要点解读[J]. 实用肿瘤杂志, 2022, 37(1): 8-15.
[26]
Wu L, Zhong W, Li A, et al. Successful treatment of EGFR T790M-mutant non-small cell lung cancer with almonertinib after osimertinib-induced interstitial lung disease: a case report and literature review[J]. Ann Transl Med, 2021, 9(11): 950.
[27]
Zhang M, Quan H, Fu L, et al. Third-generation EGFR inhibitor HS-10296 in combination with famitinib, a multi-targeted tyrosine kinase inhibitor, exerts synergistic antitumor effects through enhanced inhibition of downstream signaling in EGFR-mutant non-small cell lung cancer cells[J]. Thorac Cancer, 2021, 12(8): 1210-1218.
[28]
Liu Y, Ge X, Pang J, et al. Restricting glutamine uptake enhances NSCLC sensitivity to third-generation EGFR-TKI almonertinib[J]. Front Pharmacol, 2021, 12: 671328.
[29]
Zhu L, Zou C, Zhang Z, et al. Thoracic radiotherapy and concurrent almonertinib for unresectable stage Ⅲ EGFR-mutated non-small-cell lung cancer: a phase 2 study[J]. BMC Cancer, 2021, 21(1): 511.
[30]
Oxnard GR, Hu Y, Mileham KF, et al. Assessment of resistance mechanisms and clinical implications in patients with EGFR T790M-positive lung cancer and acquired resistance to osimertinib[J]. JAMA Oncol, 2018, 4(11): 1527-1534.
2022年第43卷第3期
12
2
0
引用本文
BibTeX
文章信息
doi: 10.13683/j.wph.2022.03.020
  • 接收时间:2021-08-26
  • 首发时间:2026-11-19
  • 出版时间:2022-03-10
补充材料
相关文章
文章信息
作者
出版历史
  • 收稿日期:2021-08-26
基金
中西药合用代谢性相互作用及其机制研究(20210037)
作者信息
    1.河北医科大学研究生学院,河北 石家庄 050017
    2.河北省人民医院药学部,河北 石家庄 050051

通讯作者:

董占军,硕士,主任药师,研究方向:临床药学、医院药学管理。
参考文献
分享链接
https://castjournals.cast.org.cn/joweb/sjlcyw/CN/10.13683/j.wph.2022.03.020
分享至
全文二维码

扫描看全文

引用本文
BibTeX
本文的引用情况
2种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏